Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders
Amy Hauck Newman, Therese Ku, Chloe J. Jordan, et al.
The Annual Review of Pharmacology and Toxicology (2021) Vol. 61, Iss. 1, pp. 609-628
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Convergent abnormalities in striatal gene networks in human cocaine use disorder and mouse cocaine administration models
Philipp Mews, Ashley M. Cunningham, Joseph R. Scarpa, et al.
Science Advances (2023) Vol. 9, Iss. 6
Open Access | Times Cited: 45
The Neurobiology of Activational Aspects of Motivation: Exertion of Effort, Effort-Based Decision Making, and the Role of Dopamine
John D. Salamone, Mercè Correa
Annual Review of Psychology (2023) Vol. 75, Iss. 1, pp. 1-32
Open Access | Times Cited: 37
Structure of the human dopamine transporter and mechanisms of inhibition
Dushyant Kumar Srivastava, Vikas Navratna, Dilip K. Tosh, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 672-677
Open Access | Times Cited: 13
The resting-state brain activity signatures for addictive disorders
Hui Zheng, Tianye Zhai, Xiao Lin, et al.
Med (2024) Vol. 5, Iss. 3, pp. 201-223.e6
Open Access | Times Cited: 11
Vigor, Effort-Related Aspects of Motivation and Anhedonia
Michael T. Treadway, John D. Salamone
Current topics in behavioral neurosciences (2022), pp. 325-353
Closed Access | Times Cited: 30
Current Perspectives on Selective Dopamine D3 Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders
Amy Hauck Newman, Zheng‐Xiong Xi, Christian Heidbreder
Current topics in behavioral neurosciences (2022), pp. 157-201
Open Access | Times Cited: 24
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
TIDAL: Topology-Inferred Drug Addiction Learning
Zailiang Zhu, Bozheng Dou, Yukang Cao, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 5, pp. 1472-1489
Open Access | Times Cited: 12
The Relationship Between Social Support and Relapse Tendency Among Those Who Struggle With Drug Addiction: Multiple Mediators of Exercise Self-Efficacy and Health-Related Quality of Life
Dongming Jia, Kai Zhang, Yuming Xu
Journal of Drug Issues (2023) Vol. 54, Iss. 1, pp. 120-133
Closed Access | Times Cited: 11
A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder
Ewa Galaj, Guo‐Hua Bi, Benjamin Klein, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 13, pp. 2309-2318
Open Access | Times Cited: 17
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
Radomír Jůza, Kamil Musílek, Eva Mezeiová, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 55-211
Closed Access | Times Cited: 17
Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D3 (D3R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics
Alessandro Bonifazi, Elizabeth Saab, Julie Sanchez, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10304-10341
Open Access | Times Cited: 10
ESG‐1‐60 and ESG‐1‐61: Novel dopamine D3 receptor‐preferring partial agonists/antagonists that inhibit cocaine taking and seeking in rodents
Omar Soler‐Cedeño, Bradley M. Keegan, Hannah Alton, et al.
British Journal of Pharmacology (2025)
Open Access
Emerging Therapeutics in the Treatment of Substance Use Disorders: A Focus on GLP-1 Receptor Agonists, D3R Antagonists, and CRF Antagonists
Khaled Draghmeh, Brian Fuehrlein
Journal of Integrative Neuroscience (2025) Vol. 24, Iss. 4
Open Access
Revealing the location and dynamics of a concealed binding site in the dopamine transporter
Rong Zhu, Walter Sandtner, Thomas Stockner, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Challenges and future trends in wearable closed-loop neuromodulation to efficiently treat methamphetamine addiction
Yun-Hsuan Chen, Jie Yang, Hemmings Wu, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 9
PET imaging of dopamine transporters and D2/D3 receptors in female monkeys: effects of chronic cocaine self-administration
Mia I Allen, Angela N. Duke, Susan H. Nader, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 10, pp. 1436-1445
Closed Access | Times Cited: 9
Leak Proof PDBBind: A Reorganized Dataset of Protein-Ligand Complexes for More Generalizable Binding Affinity Prediction
Jie Li, Xingyi Guan, Oufan Zhang, et al.
arXiv (Cornell University) (2023)
Open Access | Times Cited: 8
Series of (([1,1′-Biphenyl]-2-yl)methyl)sulfinylalkyl Alicyclic Amines as Novel and High Affinity Atypical Dopamine Transporter Inhibitors with Reduced hERG Activity
Therese Ku, Jianjing Cao, Sung Joon Won, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 2, pp. 515-532
Open Access | Times Cited: 3
Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors
Alev Ecevitoglu, Nicolette Meka, Renee A. Rotolo, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 8, pp. 1309-1317
Closed Access | Times Cited: 3
Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
Melinda Hersey, Amanda K. Bacon, Lydia G. Bailey, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 19
Toward Reducing hERG Affinities for DAT Inhibitors with a Combined Machine Learning and Molecular Modeling Approach
Kuo Hao Lee, Andrew D. Fant, Jiqing Guo, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4266-4279
Open Access | Times Cited: 16
Machine Learning Analysis of Cocaine Addiction Informed by DAT, SERT, and NET-Based Interactome Networks
Hongsong Feng, Kaifu Gao, Dong Chen, et al.
Journal of Chemical Theory and Computation (2022) Vol. 18, Iss. 4, pp. 2703-2719
Open Access | Times Cited: 12
Synthesis of Highly Porous Metal Oxide Nanoparticles for Adsorption Applications
Shubhashish Shubhashish, Alireza Shirazi Amin, Yanliu Dang, et al.
ACS Applied Nano Materials (2022) Vol. 5, Iss. 5, pp. 7078-7091
Closed Access | Times Cited: 12
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor
Pramisha Adhikari, Bing Xie, Ana Semeano, et al.
Biomolecules (2021) Vol. 11, Iss. 4, pp. 570-570
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top